Antabuse vs Naltrexone vs Acamprosate

Choosing between Antabuse, naltrexone and acamprosate is less about which medicine is “strongest” and more about what you need help with: craving, relapse prevention, or a firm deterrent to drinking. They are used for different clinical situations, and the wrong match can be ineffective or unsafe.

TL;DR: Summary

• For alcohol use disorder, acamprosate and naltrexone are usually the main craving-focused options after you have stopped drinking, while Antabuse (disulfiram) is the deterrent option because it causes an unpleasant and potentially dangerous reaction with alcohol.
• Acamprosate is mainly used to maintain abstinence and should be combined with counselling; official UK product guidance says treatment often continues for up to 1 year.
• Naltrexone can help reduce the urge to drink and may lower relapse to heavy drinking, but it cannot be used safely if you are still taking opioids. An opioid-free period is required, around 5 to 7 days for heroin and at least 10 days for methadone.
• Antabuse/disulfiram is only suitable when alcohol avoidance is very likely, because alcohol must be avoided during treatment and for up to 14 days after stopping, and reactions can begin within 15 minutes.
• If your main goal is staying sober after detox, acamprosate or naltrexone are usually the more direct choices. If you need a behavioural deterrent and can avoid alcohol reliably, disulfiram may be considered.
• None of these medicines is a standalone fix. UK guidance and product information place them alongside counselling, follow-up, relapse planning and support.

In UK practice, these medicines are usually considered once drinking has stopped and the next task is staying well. The safest choice depends on your drinking pattern, any opioid use, kidney and liver function, and how realistic full alcohol avoidance is in daily life.

What is the simplest difference between Antabuse, naltrexone and acamprosate?

Acamprosate and naltrexone mainly target relapse risk, while Antabuse targets behaviour through deterrence. NHS guidance places acamprosate or naltrexone in the craving-reduction role after stopping alcohol; disulfiram is the medicine that makes drinking physically unpleasant.

That distinction matters because these medicines are not interchangeable. If a person is struggling with urges and wants help staying abstinent after detox, acamprosate or naltrexone are usually the first medicines discussed. If a person is highly committed to avoiding alcohol and wants a strong external barrier, disulfiram may be considered.

A common misconception is that Antabuse reduces craving in the same way as the other two. It does not. Disulfiram works as a deterrent treatment, while acamprosate and naltrexone are used more directly for craving reduction or relapse prevention.

“Floralund Fredensborg combines medically supervised detox with personalised rehabilitation, which matters because alcohol medicines work best as part of a wider treatment plan.”

How do Antabuse, naltrexone and acamprosate work in the body?

Disulfiram, naltrexone and acamprosate work through different biological pathways. Disulfiram blocks alcohol metabolism, naltrexone blocks opioid-related reward signalling, and acamprosate helps stabilise brain signalling linked to abstinence.

Disulfiram blocks the enzyme acetaldehyde dehydrogenase. If alcohol is consumed, acetaldehyde builds up and can trigger flushing, nausea, headache, palpitations and other symptoms. Official UK product information says this reaction may begin within 15 minutes and can be severe or life-threatening.

Naltrexone works differently. It reduces the rewarding effect linked to alcohol and can reduce the desire to drink during abstinence and after alcohol ingestion. Acamprosate is used to maintain abstinence and is thought to help normalise disrupted excitatory and inhibitory signalling, often described through glutamate and GABAergic neurotransmission. If you hear that all three “stop you drinking”, that is only partly true. They do it by very different routes, and that affects who can take them safely.

“Floralund Fredensborg uses CBT, Motivational Interviewing and mindfulness in personalised plans, matching the counselling-based approach recommended alongside alcohol medicines.”

What are the main UK medicines used to support alcohol abstinence or reduce drinking?

In the UK, the three core medicines are acamprosate, naltrexone and disulfiram. Acamprosate and naltrexone are usually the craving-focused options; disulfiram is the deterrent option.

Each one fits a different pattern of need, risk and motivation. The practical question is not just “Does it work?” but “What does it ask of the person taking it?”

1. Acamprosate: Used to maintain abstinence after alcohol withdrawal or detox. UK product guidance says it should start once the person is abstinent, and it should be combined with counselling.
2. Naltrexone: Used to reduce the desire for alcohol and lower relapse risk. It has a key restriction: the person must be opioid-free for a safe period before starting.
3. Disulfiram (Antabuse): Used as a deterrent. It does not blunt craving directly; it creates a risky alcohol reaction, so it only suits people who can avoid alcohol reliably.

Which medicine is usually best if your goal is staying completely alcohol-free?

Acamprosate is often the clearest fit for abstinence support, while disulfiram can fit selected people who want a firm deterrent. Naltrexone also supports abstinence, especially when urges or reward-driven slips are a major issue.

If the goal is complete sobriety after detox, acamprosate is often a straightforward option because its indication is to maintain abstinence. Official product guidance also says ongoing alcohol use negates its therapeutic benefit, which tells you who it is really designed for.

Disulfiram can also support abstinence, but only when the person is very likely to avoid alcohol. That trade-off is important. A medicine that depends on strict avoidance can be useful when motivation and structure are strong, but risky when ambivalence is high. Naltrexone sits between those two patterns. It can help with abstinence, but it is often especially useful when cravings, reward expectation or repeated heavy-drinking lapses are the main problem.

Can naltrexone help if you are trying to reduce heavy drinking rather than stop completely?

Yes, naltrexone can help reduce heavy drinking risk, but UK services still assess it carefully and often use it after drinking has stopped. It is not suitable if opioids are still in your system.

The product information for naltrexone says it reduces desire for alcohol during abstinence and after alcohol ingestion. That is one reason it is often discussed when someone has repeated relapses to heavy alcohol use. Still, NHS guidance generally frames these medicines as support once a person has stopped drinking and needs help staying sober, so the exact goal should be agreed with a clinician rather than assumed.

There is a practical trade-off that people sometimes miss. If you may need opioid pain relief, or if you use heroin, methadone or other opioids, naltrexone becomes much more complicated. Pro tip: mention all opioid medicines and illicit opioid use before treatment starts, even if it feels unrelated to alcohol.

“Floralund Fredensborg offers truly anonymous advice and a 24/7 supportive community, which can help people work through medication choices and relapse risks without delay.”

How do you choose between acamprosate, naltrexone and Antabuse step by step?

The safest way to choose is to match the medicine to the goal, the medical risks and the likelihood of alcohol or opioid exposure. Acamprosate, naltrexone and disulfiram each suit a different profile.

A simple decision process can stop the comparison from becoming overwhelming.

1. Step 1: Define the goal. If the aim is full abstinence after detox, acamprosate or naltrexone usually make more sense than disulfiram as first comparisons.
2. Step 2: Check deal-breakers. Opioid use can rule out naltrexone for now. Significant renal impairment can rule out acamprosate. Unreliable alcohol avoidance can make disulfiram unsafe.
3. Step 3: Match the pattern. If craving is the main issue, think acamprosate or naltrexone. If external deterrence is the main issue, disulfiram may be the fit.
4. Step 4: Add support. If there is little counselling, follow-up or family support, the medicine may be doing too much work on its own.

What checks should happen before starting naltrexone step by step?

Naltrexone needs an opioid-safety check before anything else. The main pre-start issue is whether heroin, methadone or opioid pain medicines have been stopped for long enough.

This is the medicine where one missed detail can cause real problems, so the screening needs to be careful and honest.

1. Step 1: Confirm an opioid-free period. Official guidance says about 5 to 7 days for heroin and at least 10 days for methadone.
2. Step 2: Review liver and kidney health. The product information says to use caution in hepatic or renal impairment.
3. Step 3: Review pain management plans. If future opioid pain relief may be needed, that should be discussed before treatment.
4. Step 4: Confirm the treatment aim. If the aim is relapse prevention after stopping alcohol, naltrexone may be appropriate. If alcohol use is still chaotic and opioids are still present, it is usually the wrong starting point.

What checks should happen before starting acamprosate or Antabuse step by step?

Acamprosate needs a kidney check, and Antabuse needs a strict alcohol-avoidance check. Both medicines are safer when started only after alcohol has been stopped.

These two medicines can look simple on paper, but each has a key restriction that should not be brushed aside.

1. Step 1: Confirm abstinence. Acamprosate should start after weaning, once the person is abstinent. Disulfiram is also used when the intention is not to drink.
2. Step 2: Check renal function for acamprosate. UK product guidance lists renal impairment with serum creatinine above 120 micromol/l as a contraindication.
3. Step 3: Check alcohol exposure risk for disulfiram. The person must avoid alcohol during treatment and for up to 14 days after stopping.
4. Step 4: Plan monitoring and support. A medicine that depends on daily adherence or strict avoidance needs follow-up, not just a prescription.

What side effects and safety risks matter most?

Disulfiram carries the sharpest alcohol-related risk, naltrexone has opioid and liver-related restrictions, and acamprosate is limited mainly by kidney function. Those are the headline safety differences.

The biggest red flag is the disulfiram-alcohol reaction. UK product information says reactions can begin within 15 minutes, last for several hours, and in rare cases deaths have been reported after alcohol intake during treatment. A common misconception is that this only matters with obvious drinking. In reality, strict alcohol avoidance means checking exposures carefully and not assuming “a small amount won’t matter”.

Naltrexone’s key risk is different. It blocks opioid effects, so starting it too soon after opioid use can be dangerous and can complicate pain treatment. It also needs caution in hepatic or renal impairment. Acamprosate is often seen as the gentler option, but that does not mean “no checks needed”. Its renal restriction is clear, and it still works best when the person is already abstinent and engaged with counselling.

Do these medicines work better with counselling, aftercare and family support?

Yes. Acamprosate is explicitly meant to be combined with counselling, and all three medicines work better when relapse prevention, therapy and support are in place. Medication helps, but it does not replace treatment.

This is one of the most consistent points across NHS guidance, product information and international reviews. The WHO review found acamprosate, naltrexone and disulfiram effective versus placebo for relapse-related alcohol outcomes, with comparable numbers needed to treat in the range of 7 to 9. That is useful, but it also shows these are supportive medicines, not magic switches. If sleep, stress, trauma, family conflict or social triggers are still driving drinking, tablets alone rarely solve the whole problem.

Care usually works best when the medicine is fitted into a wider plan that may include detox, individual therapy, family work and aftercare. In settings including NHS alcohol services or residential centres like Floralund Fredensborg, the aim is usually to combine medication decisions with practical support, coping skills and a plan for what happens after the first sober weeks. That matters because the highest-risk moments are often not at the point of prescribing, but later when motivation dips, cravings return or a lapse makes someone think treatment has failed.